Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Shares Issued: 2018-2024

Historic Shares Issued for Stoke Therapeutics (STOK) over the last 7 years, with Dec 2024 value amounting to $1.7 million.

  • Stoke Therapeutics' Shares Issued rose 1689.93% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 299.05%. This contributed to the annual value of $1.7 million for FY2024, which is 210.27% up from last year.
  • Per Stoke Therapeutics' latest filing, its Shares Issued stood at $1.7 million for FY2024, which was up 210.27% from $555,000 recorded in FY2023.
  • Stoke Therapeutics' Shares Issued's 5-year high stood at $105.4 million during FY2020, with a 5-year trough of $555,000 in FY2023.
  • Its 3-year average for Shares Issued is $949,000, with a median of $570,000 in 2022.
  • Per our database at Business Quant, Stoke Therapeutics' Shares Issued crashed by 99.26% in 2021 and then soared by 210.27% in 2024.
  • Stoke Therapeutics' Shares Issued (Yearly) stood at $105.4 million in 2020, then slumped by 99.26% to $777,000 in 2021, then fell by 26.64% to $570,000 in 2022, then dropped by 2.63% to $555,000 in 2023, then spiked by 210.27% to $1.7 million in 2024.